ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,522 | 18,779 | -47,896 | -42,603 | -22,548 |
| Depreciation Amortization | 81,330 | 59,791 | 59,653 | 47,252 | 44,638 |
| Income taxes - deferred | -21,913 | -11,740 | -15,253 | -16,754 | -13,205 |
| Accounts receivable | -21,087 | 3,359 | -36,912 | -5,548 | -23,664 |
| Other Working Capital | -11,185 | 24,860 | -51,300 | -84 | -12,628 |
| Other Operating Activity | 55,394 | 23,910 | 60,505 | 21,059 | 42,674 |
| Operating Cash Flow | $64,017 | $118,959 | $-31,203 | $3,322 | $15,267 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,722 | -8,868 | -8,126 | 92 | -6,135 |
| Net Acquisitions | -401,280 | N/A | -33 | -84,494 | N/A |
| Purchase Sale Intangibles | -717 | -9,643 | -7,579 | -21,081 | -62,187 |
| Other Investing Activity | -717 | -9,643 | -7,579 | -21,081 | -62,187 |
| Investing Cash Flow | $-404,719 | $-18,511 | $-15,738 | $-105,483 | $-68,322 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 316,250 | 0 | 0 | 310,032 | 15,000 |
| Debt Issued | 325,000 | 0 | 0 | N/A | -7,500 |
| Debt Repayment | N/A | N/A | N/A | -10,862 | N/A |
| Common Stock Issued | 6,488 | 89,551 | 1,458 | 71,653 | 618 |
| Common Stock Repurchased | -10,959 | -4,987 | -1,959 | -890 | -1,523 |
| Dividend Paid | -1,625 | -1,625 | -1,625 | -190 | N/A |
| Other Financing Activity | -370,209 | -15,500 | -3,000 | -175,148 | -8,034 |
| Financing Cash Flow | $264,945 | $67,439 | $-5,126 | $194,595 | $-1,439 |
| Exchange Rate Effect | -470 | 0 | 0 | N/A | N/A |
| Beginning Cash Position | 221,121 | 53,234 | 105,301 | 12,867 | 67,361 |
| End Cash Position | 144,894 | 221,121 | 53,234 | 105,301 | 12,867 |
| Net Cash Flow | $-76,227 | $167,887 | $-52,067 | $92,434 | $-54,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,017 | 118,959 | -31,203 | 3,322 | 15,267 |
| Capital Expenditure | -16,236 | -8,868 | -8,876 | -2,557 | -6,135 |
| Free Cash Flow | 47,781 | 110,091 | -40,079 | 765 | 9,132 |